Human CellExp™ CD28, Human recombinant
CD28, Tp44
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | AAH93698 |
---|---|
Calculated MW | This protein is fused with a Fc tag at C-terminus and has a calculated MW of 41.8 kDa. |
Other Names | CD28, Tp44 |
---|---|
Gene Source | Human |
Source | HEK 293 cells |
Assay&Purity | SDS-PAGE;≥92% |
Assay2&Purity2 | N/A;≥92% |
Recombinant | Yes |
Target/Specificity | CD28 |
Application Notes | Reconstitute in sterile PBS, pH 7.4 to a concentration of 50 µg/ml |
Format | Lyophilized |
Storage | -20°C;Lyophilized |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
T-cell-specific surface glycoprotein CD28 is also known as TP44, is a single-pass type I membrane protein which contains one Ig-like V-type (immunoglobulin-like) domain. is one of the molecules expressed on T cells that provide co-stimulatory signals, which are required for T cell activation. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2). When activated by Toll-like receptor ligands, the CD80 expression is upregulated in antigen presenting cells (APCs). The CD86 expression on antigen presenting cells is constitutive. CD28 is the only B7 receptor constitutively expressed on naive T cells.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.